BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33044755)

  • 1. SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression.
    Shang W; Wang Y; Liang X; Li T; Shao W; Liu F; Cui X; Wang Y; Lv L; Chai L; Qu L; Zheng L; Jia J
    J Pathol; 2021 Feb; 253(2):148-159. PubMed ID: 33044755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression.
    Zheng L; Liang X; Li S; Li T; Shang W; Ma L; Jia X; Shao W; Sun P; Chen C; Jia J
    EBioMedicine; 2018 Dec; 38():69-78. PubMed ID: 30449701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis.
    Yu L; Ye F; Li YY; Zhan YZ; Liu Y; Yan HM; Fang Y; Xie YW; Zhang FJ; Chen LH; Ding Y; Chen KL
    Carcinogenesis; 2020 Jul; 41(5):678-688. PubMed ID: 31306481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9.
    Zhang BG; Du T; Zang MD; Chang Q; Fan ZY; Li JF; Yu BQ; Su LP; Li C; Yan C; Gu QL; Zhu ZG; Yan M; Liu B
    Oncotarget; 2014 Nov; 5(21):10584-95. PubMed ID: 25301736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis.
    Xiao JF; Sun QY; Ding LW; Chien W; Liu XY; Mayakonda A; Jiang YY; Loh XY; Ran XB; Doan NB; Castor B; Chia D; Said JW; Tan KT; Yang H; Fu XY; Lin DC; Koeffler HP
    J Pathol; 2018 Sep; 246(1):89-102. PubMed ID: 29926931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orphan nuclear receptor Nurr1 promotes Helicobacter pylori-associated gastric carcinogenesis by directly enhancing CDK4 expression.
    Shang W; Liang X; Li S; Li T; Zheng L; Shao W; Wang Y; Liu F; Ma L; Jia J
    EBioMedicine; 2020 Mar; 53():102672. PubMed ID: 32114387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.
    Wu J; Chai H; Xu X; Yu J; Gu Y
    Mol Oncol; 2020 Jun; 14(6):1397-1409. PubMed ID: 32291851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori promotes invasion and metastasis of gastric cancer cells through activation of AP-1 and up-regulation of CACUL1.
    Kong Y; Ma LQ; Bai PS; Da R; Sun H; Qi XG; Ma JQ; Zhao RM; Chen NZ; Nan KJ
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2666-78. PubMed ID: 24004834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulated WDR5 promotes gastric cancer formation by induced cyclin D1 expression.
    Sun W; Guo F; Liu M
    J Cell Biochem; 2018 Apr; 119(4):3304-3316. PubMed ID: 29125890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDM6B promotes gastric carcinogenesis and metastasis via upregulation of CXCR4 expression.
    Liu F; Wang Y; Yang Z; Cui X; Zheng L; Fu Y; Shao W; Zhang L; Yang Q; Jia J
    Cell Death Dis; 2022 Dec; 13(12):1068. PubMed ID: 36564369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression.
    Cao N; Yu Y; Zhu H; Chen M; Chen P; Zhuo M; Mao Y; Li L; Zhao Q; Wu M; Ye M
    Cell Death Dis; 2020 May; 11(5):351. PubMed ID: 32393761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.
    Hu L; Zang MD; Wang HX; Zhang BG; Wang ZQ; Fan ZY; Wu H; Li JF; Su LP; Yan M; Zhu ZQ; Yang QM; Huang Q; Liu BY; Zhu ZG
    Cell Death Dis; 2018 Feb; 9(3):278. PubMed ID: 29449539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9.
    Chen SW; Zhang Q; Xu ZF; Wang HP; Shi Y; Xu F; Zhang WJ; Wang P; Li Y
    Mol Med Rep; 2016 Oct; 14(4):3261-8. PubMed ID: 27573865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
    Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
    J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation of ANO1 promotes gastric cancer progression.
    Zeng X; Pan D; Wu H; Chen H; Yuan W; Zhou J; Shen Z; Chen S
    Biochem Biophys Res Commun; 2019 Apr; 512(1):131-136. PubMed ID: 30871776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBX1 attributes as a determinant of connexin 32 downregulation in
    Liu XM; Xu CX; Zhang LF; Huang LH; Hu TZ; Li R; Xia XJ; Xu LY; Luo L; Jiang XX; Li M
    World J Gastroenterol; 2017 Aug; 23(29):5345-5355. PubMed ID: 28839434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer.
    Liu Z; Chen Z; Fan R; Jiang B; Chen X; Chen Q; Nie F; Lu K; Sun M
    Mol Cancer; 2017 Apr; 16(1):82. PubMed ID: 28441948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACAT2 suppresses the ubiquitination of YAP1 to enhance the proliferation and metastasis ability of gastric cancer via the upregulation of SETD7.
    Zhang M; Cai F; Guo J; Liu S; Ma G; Cai M; Zhang R; Deng J
    Cell Death Dis; 2024 Apr; 15(4):297. PubMed ID: 38670954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1.
    Zhou J; Che J; Xu L; Yang W; Li Y; Zhou W; Zou S
    Bioengineered; 2022 Mar; 13(3):5737-5755. PubMed ID: 35184652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
    Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
    J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.